Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to $126.4 million.

  • Janux Therapeutics' Change in Acquisitions & Divestments rose 17979.19% to $126.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $310.4 million, marking a year-over-year increase of 5543.94%. This contributed to the annual value of $212.9 million for FY2024, which is 2341.19% down from last year.
  • Latest data reveals that Janux Therapeutics reported Change in Acquisitions & Divestments of $126.4 million as of Q3 2025, which was up 17979.19% from $94.7 million recorded in Q2 2025.
  • In the past 5 years, Janux Therapeutics' Change in Acquisitions & Divestments ranged from a high of $126.4 million in Q3 2025 and a low of $22.1 million during Q3 2021
  • For the 5-year period, Janux Therapeutics' Change in Acquisitions & Divestments averaged around $72.7 million, with its median value being $75.0 million (2023).
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 42720.7% in 2022, then plummeted by 5289.47% in 2024.
  • Janux Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $112.0 million in 2021, then decreased by 22.77% to $86.5 million in 2022, then tumbled by 48.27% to $44.8 million in 2023, then increased by 29.61% to $58.0 million in 2024, then soared by 117.88% to $126.4 million in 2025.
  • Its last three reported values are $126.4 million in Q3 2025, $94.7 million for Q2 2025, and $31.3 million during Q1 2025.